{"entity":{"type":"insider","cik":"0001276550","url":"/insider/0001276550","json_url":"/insider/0001276550.json","name":"LOUGHLIN JAMES J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":18,"first":"2004-09-22","last":"2019-02-11","span_basis":"filed_date"},"name_variants":[{"name":"LOUGHLIN JAMES J","source":"filing","n_filings":18,"first_seen":"2004-09-22","last_seen":"2019-02-11"}],"transactions":[{"id":8332704,"accession":"0001415889-19-000144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-19-000144","line_url":"/filing/0001415889-19-000144#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23466.0,"shares_display":"23,466","price_per_share":87.289,"price_display":"87.29","price_state":"stated","total_value":2048323.674,"total_display":"2,048,323.67","total_whole":"2,048,324","shares_owned_after":38636.0,"shares_owned_after_display":"38,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-07","filed_date":"2019-02-11","scope":"insider"},{"id":6737052,"accession":"0001415889-18-000872","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-18-000872","line_url":"/filing/0001415889-18-000872#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17750.0,"shares_display":"17,750","price_per_share":78.96,"price_display":"78.96","price_state":"stated","total_value":1401540.0,"total_display":"1,401,540.00","total_whole":"1,401,540","shares_owned_after":34361.0,"shares_owned_after_display":"34,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-04","filed_date":"2018-06-05","scope":"insider"},{"id":6420610,"accession":"0001209191-18-019209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-019209","line_url":"/filing/0001209191-18-019209#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9250.0,"shares_display":"9,250","price_per_share":92.01,"price_display":"92.01","price_state":"stated","total_value":851092.5,"total_display":"851,092.50","total_whole":"851,093","shares_owned_after":24361.0,"shares_owned_after_display":"24,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-13","scope":"insider"},{"id":5281382,"accession":"0001209191-17-041954","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-041954","line_url":"/filing/0001209191-17-041954","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":133.57,"price_display":"133.57","price_state":"stated","total_value":2471045.0,"total_display":"2,471,045.00","total_whole":"2,471,045","shares_owned_after":23627.0,"shares_owned_after_display":"23,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-27","scope":"insider","n_lines":2},{"id":4869071,"accession":"0001209191-17-029190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-029190","line_url":"/filing/0001209191-17-029190#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9250.0,"shares_display":"9,250","price_per_share":124.0,"price_display":"124.00","price_state":"stated","total_value":1147000.0,"total_display":"1,147,000.00","total_whole":"1,147,000","shares_owned_after":22919.0,"shares_owned_after_display":"22,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-02","scope":"insider"},{"id":4815107,"accession":"0001127602-17-010543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-010543","line_url":"/filing/0001127602-17-010543#line-1","is_derivative":false,"issuer_cik":"0001276550","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001276550","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":9.24,"price_display":"9.24","price_state":"stated","total_value":27720.0,"total_display":"27,720.00","total_whole":"27,720","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-06","filed_date":"2017-03-07","scope":"insider"},{"id":2415593,"accession":"0001209191-16-138482","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-138482","line_url":"/filing/0001209191-16-138482#line-3","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":114.1,"price_display":"114.10","price_state":"stated","total_value":3137750.0,"total_display":"3,137,750.00","total_whole":"3,137,750","shares_owned_after":22919.0,"shares_owned_after_display":"22,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-23","filed_date":"2016-08-24","scope":"insider"},{"id":3180209,"accession":"0001615774-16-004585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-16-004585","line_url":"/filing/0001615774-16-004585#line-1","is_derivative":false,"issuer_cik":"0001276550","issuer_name":"InspireMD, Inc.","issuer_ticker":"NSPR","issuer_name_source":null,"issuer_url":"/issuer/0001276550","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":29500.0,"total_display":"29,500.00","total_whole":"29,500","shares_owned_after":51501.0,"shares_owned_after_display":"51,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-21","filed_date":"2016-03-23","scope":"insider"},{"id":2907937,"accession":"0001127602-16-046331","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-16-046331","line_url":"/filing/0001127602-16-046331","is_derivative":false,"issuer_cik":"0001276550","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001276550","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":7.633810166666667,"price_display":"7.63","price_state":"stated","total_value":22901.4305,"total_display":"22,901.43","total_whole":"22,901","shares_owned_after":1720.0,"shares_owned_after_display":"1,720","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-11","filed_date":"2016-03-15","scope":"insider","n_lines":7},{"id":2101650,"accession":"0001209191-16-101961","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-101961","line_url":"/filing/0001209191-16-101961#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":104.12,"price_display":"104.12","price_state":"stated","total_value":218652.0,"total_display":"218,652.00","total_whole":"218,652","shares_owned_after":19785.0,"shares_owned_after_display":"19,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-22","filed_date":"2016-02-24","scope":"insider"},{"id":8608283,"accession":"0001140361-15-037188","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-037188","line_url":"/filing/0001140361-15-037188#line-3","is_derivative":false,"issuer_cik":"0001276550","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001276550","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":77000.0,"total_display":"77,000.00","total_whole":"77,000","shares_owned_after":19261.0,"shares_owned_after_display":"19,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-06","filed_date":"2015-10-08","scope":"insider"},{"id":6493848,"accession":"0001209191-14-054432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-054432","line_url":"/filing/0001209191-14-054432#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":91.25,"price_display":"91.25","price_state":"stated","total_value":1825000.0,"total_display":"1,825,000.00","total_whole":"1,825,000","shares_owned_after":17018.0,"shares_owned_after_display":"17,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2014-08-26","scope":"insider"},{"id":4583613,"accession":"0001144204-13-022470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-022470","line_url":"/filing/0001144204-13-022470#line-1","is_derivative":false,"issuer_cik":"0001276550","issuer_name":"InspireMD, Inc.","issuer_ticker":"NSPR","issuer_name_source":null,"issuer_url":"/issuer/0001276550","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-04-17","scope":"insider"},{"id":2408677,"accession":"0001209191-12-035087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-035087","line_url":"/filing/0001209191-12-035087#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":60.29,"price_display":"60.29","price_state":"stated","total_value":36174.0,"total_display":"36,174.00","total_whole":"36,174","shares_owned_after":5025.0,"shares_owned_after_display":"5,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-22","filed_date":"2012-06-22","scope":"insider"},{"id":5710242,"accession":"0001209191-09-025104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-025104","line_url":"/filing/0001209191-09-025104#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":39.57,"price_display":"39.57","price_state":"stated","total_value":23742.0,"total_display":"23,742.00","total_whole":"23,742","shares_owned_after":1600.0,"shares_owned_after_display":"1,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-06","filed_date":"2009-05-07","scope":"insider"},{"id":2611409,"accession":"0001005477-06-003634","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-06-003634","line_url":"/filing/0001005477-06-003634","is_derivative":false,"issuer_cik":"0000708717","issuer_name":"ALFACELL CORP","issuer_ticker":"ACEL","issuer_name_source":null,"issuer_url":"/issuer/0000708717","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":2.0357066666666666,"price_display":"2.04","price_state":"stated","total_value":15267.8,"total_display":"15,267.80","total_whole":"15,268","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-25","filed_date":"2006-07-26","scope":"insider","n_lines":2},{"id":1308373,"accession":"0001140361-05-003865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-05-003865","line_url":"/filing/0001140361-05-003865","is_derivative":false,"issuer_cik":"0000027096","issuer_name":"DATASCOPE CORP","issuer_ticker":"DSCP","issuer_name_source":null,"issuer_url":"/issuer/0000027096","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock par value $.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":29.8,"price_display":"29.80","price_state":"stated","total_value":29800.0,"total_display":"29,800.00","total_whole":"29,800","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-19","filed_date":"2005-05-20","scope":"insider","n_lines":2},{"id":205990,"accession":"0001005477-04-003382","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-04-003382","line_url":"/filing/0001005477-04-003382#line-2","is_derivative":false,"issuer_cik":"0000708717","issuer_name":"ALFACELL CORP","issuer_ticker":"ACEL","issuer_name_source":null,"issuer_url":"/issuer/0000708717","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":5060.0,"total_display":"5,060.00","total_whole":"5,060","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-09-22","filed_date":"2004-09-22","scope":"insider"},{"id":205989,"accession":"0001005477-04-003382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-04-003382","line_url":"/filing/0001005477-04-003382#line-1","is_derivative":false,"issuer_cik":"0000708717","issuer_name":"ALFACELL CORP","issuer_ticker":"ACEL","issuer_name_source":null,"issuer_url":"/issuer/0000708717","owner_cik":"0001276550","owner_name":"LOUGHLIN JAMES J","owner_display_name":"LOUGHLIN JAMES J","owner_url":"/insider/0001276550","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":6300.0,"total_display":"6,300.00","total_whole":"6,300","shares_owned_after":1400.0,"shares_owned_after_display":"1,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-09-21","filed_date":"2004-09-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000816284","name":"CELGENE CORP /DE/","url":"/issuer/0000816284","role":"Director","n_filings":10,"first_seen":"2009-05-07","last_seen":"2019-02-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001472091","name":"Edge Therapeutics, Inc.","url":"/issuer/0001472091","role":"Director","n_filings":3,"first_seen":"2015-10-08","last_seen":"2017-03-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001433607","name":"InspireMD, Inc.","url":"/issuer/0001433607","role":"Director","n_filings":2,"first_seen":"2013-04-17","last_seen":"2016-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000708717","name":"ALFACELL CORP","url":"/issuer/0000708717","role":"Director","n_filings":2,"first_seen":"2004-09-22","last_seen":"2006-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000027096","name":"DATASCOPE CORP","url":"/issuer/0000027096","role":"Director","n_filings":1,"first_seen":"2005-05-20","last_seen":"2005-05-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001276550","retrieved_at":"2026-08-26T02:04:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}